Cited by 565Schizophrenia research and treatmentNeurotransmitter Receptor Influence on BehaviorParkinson's Disease Mechanisms and Treatments

The DOI matches its Crossref record; 88 of the 89 references it cites were found in a registry or an index.

Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia

Kegeles, Lawrence S., Abi-Dargham, Anissa, Frankle, W. Gordon, Gil, Roberto, Cooper, Thomas B., Slifstein, Mark, Hwang, Dah-Ren, Huang, Yiyun, Haber, Suzanne N., Laruelle, Marc·2010·Archives of General Psychiatry

DOI 10.1001/archgenpsychiatry.2010.10

Open this paper in CoChat — free account

Abstract

CONTEXT: A long-standing version of the dopamine hypothesis of schizophrenia postulates that hyperactivity of dopaminergic transmission at D(2) receptors in the limbic striatum is associated with the illness and that blockade of mesolimbic D(2) receptors is responsible for the antipsychotic action of D(2) receptor antagonists. OBJECTIVE: To localize dopaminergic hyperactivity within the striatum in schizophrenia. DESIGN: Case-control study. SETTING: Inpatient research unit. PARTICIPANTS: Eighteen untreated patients with schizophrenia and 18 healthy control subjects matched for age, sex, ethnicity, parental socioeconomic status, cigarette smoking, and weight. MAIN OUTCOME MEASURES: Percentage change in dopamine D(2) receptor availability in striatal subregions within each subject measured by positron emission tomography with carbon 11-labeled raclopride before and during pharmacologically induced dopamine depletion. RESULTS: In the associative striatum, acute dopamine depletion resulted in a larger increase in D(2) receptor availability in patients with schizophrenia (mean [SD], 15% [7%]) than in control subjects (10% [7%], P = .045), suggesting higher synaptic dopamine concentration. Within the associative striatum, this effect was most pronounced in the precommissural dorsal caudate (15% [8%] in patients vs 9% [8%] in controls, P = .03). No between-group differences were observed in the limbic and sensorimotor striatum. CONCLUSIONS: These findings suggest that schizophrenia is associated with elevated dopamine function in associative regions of the striatum. Because the precommissural dorsal caudate processes information from the dorsolateral prefrontal cortex, this observation also suggests that elevated subcortical dopamine function might adversely affect performance of the dorsolateral prefrontal cortex in schizophrenia. On the other hand, the absence of a group difference in the limbic striatum brings into question the therapeutic relevance of the mesolimbic selectivity of second-generation antipsychotic drugs.

Integrity signals

Registry

Crossref · 10.1001/archgenpsychiatry.2010.10

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527
Four Factor Index of Social Status
Paschou, R. (1975) · Cited by 6,989
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Four Factor Index of Social Status [1975]
Hollingshead, A. B. (1975) · Cited by 5,151
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop
Parent, A., & Hazrati, L.-N. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(94)00007-c · Cited by 2,161
Dopamine in schizophrenia: a review and reconceptualization
Davis, K. L., Kahn, R. S., Ko, G., & Davidson, M. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.11.1474 · Cited by 2,051
Physiologic Dysfunction of Dorsolateral Prefrontal Cortex in Schizophrenia
Weinberger, D. R. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800020020004 · Cited by 2,025
Negative v Positive Schizophrenia
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070025006 · Cited by 2,008

Show all 89 references

Sorted by citations

Animal models of neuropsychiatric disorders
Nestler, E. J., & Hyman, S. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2647 · Cited by 2,023
The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment: Meta-analysis of Imaging Studies
Howes, O. D., Kambeitz, J., Kim, E., Stahl, D., Slifstein, M., Abi-Dargham, A., & Kapur, S. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2012.169 · Cited by 967
Self-citation
Schizophrenia, dopamine and the striatum: From biology to symptoms
McCutcheon, R. A., Abi-Dargham, A., & Howes, O. D. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2018.12.004 · Cited by 763
Self-citation
Glutamate and dopamine in schizophrenia: An update for the 21 st century
Howes, O., McCutcheon, R., & Stone, J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114563634 · Cited by 702
The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder
del Campo, N., Chamberlain, S. R., Sahakian, B. J., & Robbins, T. W. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.036 · Cited by 685
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology
Barnes, T. R. E., Drake, R., Paton, C., Cooper, S. J., Deakin, J. F. W., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I. R., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 615
The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia
Howes, O. D., McCutcheon, R. A., Owen, M. J., & Murray, R. M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.07.014 · Cited by 640
Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
McCutcheon, R. A., Krystal, J. H., & Howes, O. D. (2020) · World Psychiatry · doi:10.1002/wps.20693 · Cited by 612
Altering the course of schizophrenia: progress and perspectives
Millan, M. J., Andrieux, A., Bartzokis, G., Cadenhead, K., Dazzan, P., Fusar-Poli, P., Gallinat, J., Giedd, J., Grayson, D. R., Heinrichs, M., et al. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.28 · Cited by 516
The Role of Dopamine in Schizophrenia from a Neurobiological and Evolutionary Perspective: Old Fashioned, but Still in Vogue
Brisch, R., Saniotis, A., Wolf, R. J., Bielau, H., Bernstein, H., Steiner, J. H., Bogerts, B., Braun, A. K., Jankowski, Z., Kumaritlake, J., et al. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00047 · Cited by 575
Negative Symptoms of Schizophrenia Are Associated with Abnormal Effort-Cost Computations
Gold, J. M., Strauss, G. P., Waltz, J. A., Robinson, B. M., Brown, J. K., & Frank, M. J. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.12.022 · Cited by 421
The effects of social isolation stress and discrimination on mental health
Brandt, L., Liu, S., Heim, C. C., & Heinz, A. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02178-4 · Cited by 549
Antipsychotics: Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology
Kaar, S. J., Natesan, S., McCutcheon, R. A., & Howes, O. D. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107704 · Cited by 404
Association of Thalamic Dysconnectivity and Conversion to Psychosis in Youth and Young Adults at Elevated Clinical Risk
Anticevic, A., Haut, K. M., Murray, J. D., Repovš, G., Yang, G., Diehl, C., McEwen, S. C., Bearden, C. E., Addington, J., Goodyear, B. G., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0566 · Cited by 387
Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia
Lodge, D. J., & Grace, A. A. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.05.001 · Cited by 349
Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience
Kesby, J. P., Eyles, D. W., McGrath, J. J., & Scott, J. G. (2018) · Translational Psychiatry · doi:10.1038/s41398-017-0071-9 · Cited by 382
Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology
Salamone, J. D., Yohn, S. E., López-Cruz, L., San Miguel, N., & Correa, M. (2016) · Brain · doi:10.1093/brain/aww050 · Cited by 350
Dopamine Synthesis Capacity in Patients With Treatment-Resistant Schizophrenia
Demjaha, A., Murray, R. M., McGuire, P. K., Kapur, S., & Howes, O. D. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12010144 · Cited by 355
Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [ 18 F]-DOPA PET Imaging Study
Howes, O. D., Bose, S. K., Turkheimer, F., Valli, I., Egerton, A., Valmaggia, L. R., Murray, R. M., & McGuire, P. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11010160 · Cited by 343
Ventral Striatal Activation During Reward Processing in Psychosis
Raduà, J., Schmidt, A., Borgwardt, S., Heinz, A., Schlagenhauf, F., McGuire, P. K., & Fusar‐Poli, P. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.2196 · Cited by 357
Has an Angel Shown the Way? Etiological and Therapeutic Implications of the PCP/NMDA Model of Schizophrenia
Javitt, D. C., Zukin, S. R., Heresco-Levy, U., & Umbricht, D. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs069 · Cited by 322
Connectivity-Based Functional Analysis of Dopamine Release in the Striatum Using Diffusion-Weighted MRI and Positron Emission Tomography
Tziortzi, A. C., Haber, S. N., Searle, G. E., Tsoumpas, C., Long, C. J., Shotbolt, P., Douaud, G., Jbabdi, S., Behrens, T. E. J., Rabiner, E. A., et al. (2013) · Cerebral Cortex · doi:10.1093/cercor/bhs397 · Cited by 330
Self-citation
Defining the locus of dopaminergic dysfunction in schizophrenia: A meta-analysis and test of the mesolimbic hypothesis
McCutcheon, R., Beck, K., Jauhar, S., & Howes, O. D. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx180 · Cited by 305
An integrative perspective on the role of dopamine in schizophrenia
Maia, T. V., & Frank, M. J. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.05.021 · Cited by 293
Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings
Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299
Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy
Mao, X. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1519 · Cited by 296
Pathway-Specific Dopamine Abnormalities in Schizophrenia
Weinstein, J. J., Chohan, M. O., Slifstein, M., Kegeles, L. S., Moore, H. M., & Abi‐Dargham, A. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.03.2104 · Cited by 308
Self-citation
Functional Dysconnectivity of Corticostriatal Circuitry as a Risk Phenotype for Psychosis
Fornito, A., Harrison, B. J., Goodby, E., Dean, A., Ooi, C., Nathan, P. J., Lennox, B. R., Jones, P. B., Suckling, J., & Bullmore, E. T. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1976 · Cited by 279
The hippocampal-striatal axis in learning, prediction and goal-directed behavior
Pennartz, C. M. A., Ito, R., Verschure, P. F. M. J., Battaglia, F. P., & Robbins, T. W. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.08.001 · Cited by 287
Increased stress-induced dopamine release in psychosis
Mizrahi, R., Addington, J., Rusjan, P. M., Suridjan, I., Ng, A., Boileau, I., Pruessner, J. C., Remington, G., Houle, S., & Wilson, A. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.009 · Cited by 277
Integrating the Neurodevelopmental and Dopamine Hypotheses of Schizophrenia and the Role of Cortical Excitation-Inhibition Balance
Howes, O. D., & Shatalina, E. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.06.017 · Cited by 279
Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second Cohort
Egerton, A., Chaddock, C. A., Winton-Brown, T. T., Bloomfield, M. A. P., Bhattacharyya, S., Allen, P., McGuire, P. K., & Howes, O. D. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.017 · Cited by 253
Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain
Cassidy, C., Zucca, F. A., Girgis, R. R., Baker, S. C., Weinstein, J. J., Sharp, M. E., Bellei, C., Valmadre, A., Vanegas‐Arroyave, N., Kegeles, L. S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1807983116 · Cited by 245
Self-citation
Psychotic Disorders
Lieberman, J. A., & First, M. B. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1801490 · Cited by 265
Neuroimaging Biomarkers in Schizophrenia
Kraguljac, N. V., McDonald, W. M., Widge, A. S., Rodríguez, C. I., Tohen, M. F., & Nemeroff, C. B. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20030340 · Cited by 252
Connectomics: A new paradigm for understanding brain disease
Fornito, A., & Bullmore, E. T. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.02.011 · Cited by 247
A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia
Jauhar, S., Nour, M. M., Veronese, M., Rogdaki, M., Bonoldi, I., Azis, M., Turkheimer, F., McGuire, P., Young, A. H., & Howes, O. D. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.2943 · Cited by 233
Dopamine D2 receptors regulate the anatomical and functional balance of basal ganglia circuitry
Cazorla, M., de Carvalho, F. D., Chohan, M. O., Shegda, M., Chuhma, N., Rayport, S., Ahmari, S. E., Moore, H., & Kellendonk, C. (2014) · Neuron · doi:10.1016/j.neuron.2013.10.041 · Cited by 226
Higher Levels of Glutamate in the Associative-Striatum of Subjects with Prodromal Symptoms of Schizophrenia and Patients with First-Episode Psychosis
de la Fuente‐Sandoval, C., León-Ortíz, P., Favila, R., Stephano, S., Mamo, D. C., Ramírez‐Bermúdez, J., & Graff‐Guerrero, A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.65 · Cited by 235
Mechanisms underlying dorsolateral prefrontal cortex contributions to cognitive dysfunction in schizophrenia
Smucny, J., Dienel, S. J., Lewis, D. A., & Carter, C. S. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01089-0 · Cited by 231
Glutamatergic model psychoses: prediction error, learning, and inference
Corlett, P. R., Honey, G. D., Krystal, J. H., & Fletcher, P. C. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.163 · Cited by 229
Alterations of the Brain Reward System in Antipsychotic Naïve Schizophrenia Patients
Nielsen, M. Ø., Rostrup, E., Wulff, S., Bak, N. K., Lublin, H., Kapur, S., & Glenthoj, B. Y. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.02.007 · Cited by 224
Mesolimbic dopamine release is linked to symptom severity in pathological gambling
Joutsa, J., Johansson, J., Niemelä, S., Ollikainen, A., Hirvonen, M. M., Piepponen, P., Arponen, E., Alho, H., Voon, V., Rinne, J. O., et al. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.02.006 · Cited by 209
Midbrain dopamine function in schizophrenia and depression: A post-mortem and positron emission tomographic imaging study
Howes, O. D., Williams, M., Ibrahim, K., Leung, G., Egerton, A., McGuire, P. K., & Turkheimer, F. (2013) · Brain · doi:10.1093/brain/awt264 · Cited by 198
N-Methyl-D-Aspartate Receptor Antagonist Effects on Prefrontal Cortical Connectivity Better Model Early Than Chronic Schizophrenia
Anticevic, A., Corlett, P. R., Cole, M. W., Savic, A., Gancsos, M., Tang, Y., Repovs, G., Murray, J. D., Driesen, N. R., Morgan, P. T., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.07.022 · Cited by 181
Amotivation in Schizophrenia: Integrated Assessment With Behavioral, Clinical, and Imaging Measures
Wolf, D. H., Satterthwaite, T. D., Kantrowitz, J. J., Katchmar, N., Vandekar, L., Elliott, M. A., & Ruparel, K. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu026 · Cited by 216
Schizophrenia: from neurochemistry to circuits, symptoms and treatments
Howes, O. D., Bukala, B. R., & Beck, K. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00904-0 · Cited by 221
A perceptual inference mechanism for hallucinations linked to striatal dopamine
Cassidy, C. M., Balsam, P. D., Weinstein, J. J., Rosengard, R. J., Slifstein, M., Daw, N. D., Abi-Dargham, A., & Horga, G. (2018) · Current Biology · doi:10.1016/j.cub.2017.12.059 · Cited by 176
Self-citation
Estimates of projection overlap and zones of convergence within frontal-striatal circuits
Averbeck, B. B., Lehman, J., Jacobson, M., & Haber, S. N. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.5806-12.2014 · Cited by 179
Self-citation
Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study
Jauhar, S., Veronese, M., Nour, M. M., Rogdaki, M., Hathway, P., Turkheimer, F. E., Stone, J., Egerton, A., McGuire, P., Kapur, S., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0042-4 · Cited by 183
Schizophrenia and the eye
Silverstein, S. M., & Rosen, R. B. (2015) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2015.03.004 · Cited by 189
Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study.
de la Fuente-Sandoval, C., León-Ortíz, P., Azcárraga, M., Stephano, S., Favila, R., Díaz-Galvis, L., Alvarado-Alanis, P., Ramírez-Bermúdez, J., & Graff-Guerrero, A. (2013) · JAMA psychiatry · doi:10.1001/jamapsychiatry.2013.289 · Cited by 193
Prefrontal cortical network connections: key site of vulnerability in stress and schizophrenia
Arnsten, A. F. T. (2011) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2011.02.006 · Cited by 182
Schizophrenia: from dopaminergic to glutamatergic interventions
Laruelle, M. A. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.01.001 · Cited by 181
Self-citation
Dysfunctional Prefrontal Gamma-Band Oscillations Reflect Working Memory and Other Cognitive Deficits in Schizophrenia
Senkowski, D., & Gallinat, J. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.02.034 · Cited by 179
Integrative Brain Network and Salience Models of Psychopathology and Cognitive Dysfunction in Schizophrenia
Menon, V., Palaniyappan, L. K., & Supekar, K. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.09.029 · Cited by 178
Altered Striatal Functional Connectivity in Subjects With an At-Risk Mental State for Psychosis
Dandash, O., Fornito, A., Lee, J., Keefe, R. S. E., Chee, M. W. L., Adcock, R. A., Pantelis, C., Wood, S. J., & Harrison, B. J. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt093 · Cited by 165
Early Detection and Preventive Intervention in Schizophrenia: From Fantasy to Reality
Lieberman, J. A., Small, S. A., & Girgis, R. R. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19080865 · Cited by 165
The Circuitry of Dopamine System Regulation and its Disruption in Schizophrenia: Insights Into Treatment and Prevention.
Grace, A., & Gomes, F. V. (2019) · Schizophrenia bulletin · doi:10.1093/schbul/sbx199 · Cited by 143
Structural and functional brain abnormalities in schizophrenia: A cross-sectional study at different stages of the disease
Zhao, C., Zhu, J., Liu, X., Pu, C., Lai, Y., Chen, L., Yu, X., & Hong, N. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.12.017 · Cited by 153
Cognitive Impairment Associated with Schizophrenia: From Pathophysiology to Treatment
Javitt, D. C. (2022) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-051921-093250 · Cited by 176
Disambiguating ventral striatum fMRI-related bold signal during reward prediction in schizophrenia
Morris, R. W., Vercammen, A., Lenroot, R., Moore, L., Langton, J. M., Short, B., Kulkarni, J., Curtis, J., O'Donnell, M., Weickert, C. S., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.75 · Cited by 149
Don't Worry, Be Happy: Endocannabinoids and Cannabis at the Intersection of Stress and Reward
Volkow, N. D., Hampson, A. J., & Baler, R. (2016) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104615 · Cited by 159
Dopamine’s Actions in Primate Prefrontal Cortex: Challenges for Treating Cognitive Disorders
Arnsten, A. F. T., Wang, M., & Paspalas, C. D. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010512 · Cited by 149
Impaired Prefrontal-Basal Ganglia Functional Connectivity and Substantia Nigra Hyperactivity in Schizophrenia
Yoon, J. H., Minzenberg, M., Raouf, S., D’Esposito, M., & Carter, C. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.018 · Cited by 146
Visual Perception Disturbances in Schizophrenia: A Unified Model
Silverstein, S. M. (2016) · Nebraska Symposium on Motivation/The Nebraska symposium on motivation · doi:10.1007/978-3-319-30596-7_4 · Cited by 147
Neurovascular coupling to D2/D3 dopamine receptor occupancy using simultaneous PET/functional MRI
Sander, C. Y. M., Hooker, J. M., Catana, C., Normandin, M. D., Alpert, N. M., Knudsen, G. M., Vanduffel, W., Rosen, B. R., & Mandeville, J. B. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220512110 · Cited by 139
Drug models of schizophrenia
Steeds, H., Carhart-Harris, R. L., & Stone, J. M. (2014) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125314557797 · Cited by 143
Abnormalities in Hemispheric Specialization of Caudate Nucleus Connectivity in Schizophrenia
Mueller, S., Wang, D., Pan, R., Holt, D. J., & Liu, H. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.3176 · Cited by 133
Dysregulation of Midbrain Dopamine System and the Pathophysiology of Schizophrenia
Sonnenschein, S. F., Gomes, F. V., & Grace, A. A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00613 · Cited by 138
Increased Intrinsic Brain Activity in the Striatum Reflects Symptom Dimensions in Schizophrenia
Sorg, C., Manoliu, A., Neufang, S., Myers, N. E., Peters, H., Schwerthöffer, D., Scherr, M., Mühlau, M., Zimmer, C., Drzezga, A. E., et al. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr184 · Cited by 133
Tardive dyskinesia is caused by maladaptive synaptic plasticity: A hypothesis
Teo, J., Edwards, M. J., & Bhatia, K. P. (2012) · Movement Disorders · doi:10.1002/mds.25107 · Cited by 133
Development, wiring and function of dopamine neuron subtypes
Garritsen, O., van Battum, E. Y., Grossouw, L. M., & Pasterkamp, R. J. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00669-3 · Cited by 128
Altered Spontaneous Brain Activity in Schizophrenia: A Meta-Analysis and a Large-Sample Study
Xu, Y., Zhuo, C., Qin, W., Zhu, J., & Yu, C. (2015) · BioMed Research International · doi:10.1155/2015/204628 · Cited by 128
Reduced Proactive Inhibition in Schizophrenia Is Related to Corticostriatal Dysfunction and Poor Working Memory
Zandbelt, B. B., van Buuren, M., Kahn, R. S., & Vink, M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.07.028 · Cited by 126
Translational studies of goal-directed action as a framework for classifying deficits across psychiatric disorders
Griffiths, K. R., Morris, R. W., & Balleine, B. W. (2014) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2014.00101 · Cited by 118
Stress during critical periods of development and risk for schizophrenia
Gomes, F. V., Zhu, X., & Grace, A. A. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.01.030 · Cited by 128
Striatal Presynaptic Dopamine in Schizophrenia, Part I: Meta-Analysis of Dopamine Active Transporter (DAT) Density
Fusar‐Poli, P., & Meyer‐Lindenberg, A. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr111 · Cited by 125
Aberrant intrinsic brain activity and cognitive deficit in first-episode treatment-naive patients with schizophrenia
He, Z., Deng, W., Li, M., Chen, Z., Jiang, L., Wang, Q., Huang, C., Collier, D. A., Gong, Q., Ma, X., et al. (2012) · Psychological Medicine · doi:10.1017/s0033291712001638 · Cited by 126
The impact of Disrupted-in-Schizophrenia 1 (DISC1) on the dopaminergic system: a systematic review
Dahoun, T., Trossbach, S. V., Brandon, N., Korth, C., & Howes, O. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.282 · Cited by 118
Schizophrenia and dopamine receptors
Seeman, P. M. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.06.005 · Cited by 119
A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment
del Campo, N., Fryer, T. D., Hong, Y. T., Smith, R., Brichard, L., Acosta-Cabronero, J., Chamberlain, S. R., Tait, R., Izquierdo, D., Regenthal, R., et al. (2013) · Brain · doi:10.1093/brain/awt263 · Cited by 113
Mechanisms of Working Memory Impairment in Schizophrenia
Van Snellenberg, J. X., Girgis, R. R., Horga, G., van de Giessen, E., Slifstein, M., Ojeil, N., Weinstein, J. J., Moore, H., Lieberman, J. A., Shohamy, D., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.02.017 · Cited by 123
Self-citation
Aberrant Salience, Information Processing, and Dopaminergic Signaling in People at Clinical High Risk for Psychosis
Howes, O. D., Hird, E. J., Adams, R. A., Corlett, P. R., & McGuire, P. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.03.012 · Cited by 110
An integrative framework for perceptual disturbances in psychosis
Horga, G., & Abi-Dargham, A. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0234-1 · Cited by 103
Self-citation
Testosterone regulation of sex steroid-related mRNAs and dopamine-related mRNAs in adolescent male rat substantia nigra
Purves-Tyson, T. D., Handelsman, D. J., Double, K. L., Owens, S. J., Bustamante, S., & Weickert, C. S. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-95 · Cited by 111
Testosterone induces molecular changes in dopamine signaling pathway molecules in the adolescent male rat nigrostriatal pathway
Purves-Tyson, T. D., Owens, S. J., Double, K. L., Desai, R., Handelsman, D. J., & Weickert, C. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091151 · Cited by 109
“development of psychosis [7,8] but the underlying molecular cause(s) of this dopamine dysregulation are unknown.”
Background
Adversity in childhood linked to elevated striatal dopamine function in adulthood
Egerton, A., Valmaggia, L. R., Howes, O. D., Day, F., Chaddock, C. A., Allen, P., Winton-Brown, T. T., Bloomfield, M. A. P., Bhattacharyya, S., Chilcott, J., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.06.005 · Cited by 103
Striatal dopamine release in schizophrenia comorbid with substance dependence
Thompson, J. L., Urban, N., Slifstein, M., Xu, X., Kegeles, L. S., Girgis, R. R., Beckerman, Y., Harkavy‐Friedman, J., Gil, R. B., & Abi‐Dargham, A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.109 · Cited by 107
Self-citation
Core, social and moral disgust are bounded: A review on behavioral and neural bases of repugnance in clinical disorders
Vicario, C. M., Rafal, R. D., Martino, D., & Avenanti, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.05.008 · Cited by 109
Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction
Plitman, E., de la Fuente‐Sandoval, C., Reyes-Madrigal, F., Chavez, S., Gómez-Cruz, G., León-Ortíz, P., & Graff‐Guerrero, A. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv118 · Cited by 99
White matter tract abnormalities between rostral middle frontal gyrus, inferior frontal gyrus and striatum in first-episode schizophrenia
Quan, M., Lee, S.-H., Kubicki, M., Kikinis, Z., Rathi, Y., Seidman, L. J., Mesholam-Gately, R. I., Goldstein, J. M., McCarley, R. W., Shenton, M. E., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2012.11.028 · Cited by 97
Ventral striatal hypoactivation is associated with apathy but not diminished expression in patients with schizophrenia
Kirschner, M., Hager, O. M., Bischof, M., Hartmann-Riemer, M. N., Kluge, A., Seifritz, E., Tobler, P. N., & Kaiser, S. (2016) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.140383 · Cited by 96
Molecular substrates of schizophrenia: homeostatic signaling to connectivity
Landek‐Salgado, M. A., Faust, T. E., & Sawa, A. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.141 · Cited by 95
In vivo functional diversity of midbrain dopamine neurons within identified axonal projections
Farassat, N., Costa, K. M., Stojanovic, S., Albert, S., Kovacheva, L., Shin, J., Egger, R., Somayaji, M., Duvarci, S., Schneider, G., et al. (2019) · eLife · doi:10.7554/elife.48408 · Cited by 96
Does the dopamine hypothesis explain schizophrenia?
Lau, C. I., Wang, H.-C., Hsu, J.-L., & Liu, M. (2013) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0011 · Cited by 102
NMDA Receptor Internalization by Autoantibodies: A Reversible Mechanism Underlying Psychosis?
Masdeu, J. C., Dalmau, J. O., & Berman, K. F. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.02.006 · Cited by 92
Modulatory effects of cannabinoids on brain neurotransmission
Cohen, K., Weizman, A., & Weinstein, A. M. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14407 · Cited by 98
The pathophysiological impact of stress on the dopamine system is dependent on the state of the critical period of vulnerability
Gomes, F. V., Zhu, X., & Grace, A. A. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0514-1 · Cited by 91
Trace amine-associated receptor 1 (TAAR1) agonism as a new treatment strategy for schizophrenia and related disorders
Halff, E. F., Rutigliano, G., Garcia-Hidalgo, A., & Howes, O. D. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.10.010 · Cited by 90

Authors: Kegeles, L. S., Abi-Dargham, A., Frankle, W. G., Gil, R., Cooper, T. B., Slifstein, M., Hwang, D.-R., Huang, Y., Haber, S. N., & Laruelle, M.
Affiliations: Columbia University Irving Medical Center (US)
ORCID: Kegeles, Lawrence S.
Frankle, W. Gordon
Cooper, Thomas B.
Slifstein, Mark
Huang, Yiyun
Haber, Suzanne N.
Venue: Archives of General Psychiatry
Publisher: American Medical Association (AMA)
Published: 2010-03-01
Volume: 67
Issue: 3
Pages: 231
ISSN: 0003-990X (ISSN-L)
DOI: 10.1001/archgenpsychiatry.2010.10
OpenAlex: W1999984108
Cited by: 565
References: 89
Citations by year: 2026: 17 · 2025: 26 · 2024: 33 · 2023: 25 · 2022: 42 · 2021: 23 · 2020: 32 · 2019: 42 · 2018: 32 · 2017: 38 · 2016: 45 · 2015: 41 · 2014: 47 · 2013: 32 · 2012: 47
FWCI: 25.78
Type: journal article
Language: en
Open access: closed
Locations: Archives of General Psychiatry (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of Mental Health (K02MH01603-01, K02MH001603, R01MH054192)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords: schizophrenia, synaptic dopamine, associative striatum, dorsal caudate, dopamine depletion, mesolimbic dopamine system, dopamine hypothesis of schizophrenia, atypical antipsychotics, dorsolateral prefrontal cortex, positron emission tomography, raclopride
MeSH terms: Adult, Brain Mapping, Carbon Radioisotopes, Caudate Nucleus, Corpus Striatum, Dopamine, Female, Humans, Image Processing, Computer-Assisted, Male, Synaptic Transmission, Putamen, Schizophrenia, Synapses, Case-Control Studies, Prefrontal Cortex, Receptors, Dopamine D2, alpha-Methyltyrosine, Raclopride, Positron-Emission Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks